Schizophrenia from a neuropsychiatric perspective

Mount Sinai Journal of Medicine

Volumn 73, Issue 7, 2006, Pages 993-998

  Bowie, Christopher R ^a   Harvey, Philip D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cognition; Neuropsychiatry; Schizophrenia

Indexed keywords

AWARENESS; BLUNTED AFFECT; COGNITIVE DEFECT; COMPREHENSION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; HALLUCINATION; HUMAN; LOGORRHEA; NEUROLOGIC EXAMINATION; NEUROPSYCHIATRY; PATIENT CARE; PSYCHOLOGIC ASSESSMENT; REVIEW; SCHIZOPHRENIA; SELF CONCEPT; SPEECH DISORDER; SYMPTOM; TIME PERCEPTION;

ATTENTION; AWARENESS; COGNITION; CONSCIOUSNESS; DEPRESSION; HUMANS; MEMORY; RECOVERY OF FUNCTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 33846018030     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Amador XF, Flaum M, Andreasen NC, et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry 1994; 51(16):826-836.
2. Bowie CR, Twamley EW, Anderson H, et al. Self-assessment of functional status in schizophrenia. J Psychiatr Res 2006; in press.
3. Stirling JD, Hellewell JS, Ndlovu D. Self-monitoring dysfunction and the positive symptoms of schizophrenia. Psychopathology 2001; 34(4):198-202.
4. Knoblich G, Stottmeister F, Kircher T. Self-monitoring in patients with schizophrenia. Psychol Med 2004; 34(8):1561-1569.
5. Franck N, Farrer C, Georgieff N, et al. Defective recognition of one's own actions in patients with schizophrenia. Am J Psychiatry 2001; 158(3):454-459.
6. Blakemore SJ, Smith J, Steel R, et al. The perception of self-produced sensory stimuli in patients with auditory hallucinations and passivity experiences: evidence for a breakdown in self-monitoring. Psychol Med 2000; 30(5):1131-1139.
7. Keefe RS, Poe MP, McEvoy JP, Vaughan A. Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications. Psychopharmacology (Berl) 2003; 169(3-4):383-389.
8. Keefe RS, Arnold MC, Bayen UJ, et al. Source-monitoring deficits for self-generated stimuli in schizophrenia: multinomial modeling of data from three sources. Schizophr Res 2002; 57(1):51-67.
9. Brebion G, Amador X, David A, et al. Positive symptomatology and source-monitoring failure in schizophrenia - an analysis of symptom-specific effects. Psychiatry Res 2000; 95(2):119-131.
10. Kee KS, Kern RS, Green MF. Perception of emotion and neurocognitive functioning in schizophrenia: what's the link? Psychiatry Res 1998; 81(1):57-65
11. Kohler CG, Bilker W, Hagendoorn M, et al. Emotion recognition deficit in schizophrenia: association with symptomatology and cognition. Biol Psychiatry 2000; 48(2):127-136.
12. Frith U, Morton J, Leslie AM. The cognitive basis of a biological disorder: autism. Trends Neurosci 1991; 14(10):433-438.
13. Pickup GJ, Frith CD. Theory of mind impairments in schizophrenia: symptomatology, severity and specificity. Psychological Med 2001; 31:207-220.
14. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153:321-330.
15. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull 2000; 26:119-136.
16. Bowie CR, Reichenberg A, Patterson TL, et al. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry 2006; 163(3):418-425.
17. Rosenheck R, Leslie D, Keefe R, et al. Barriers to employment for people with schizophrenia. Am J Psychiatry 2006; 163(3):411-417.
18. Silver H, Shlomo N. Perception of facial emotions in chronic schizophrenia does not correlate with negative symptoms but correlates with cognitive and motor dysfunction. Schizophr Res 2001; 52(3):265-273.
19. Vauth R, Rusch N, Wirtz M, Corrigan PW. Does social cognition influence the relation between neurocognitive deficits and vocational functioning in schizophrenia? Psychiatry Res 2004; 128(2):155-165.
20. Koren D, Seidman LJ, Goldsmith M, Harvey PD. Real-world cognitive- and metacognitive-dysfunction in schizophrenia: a new approach for measuring (and remediating) more "right stuff." Schizophr Bull 2006; 32(2):310-326.
21. Bowie CR, Harvey PD, Moriarty PJ, et al. Cognitive assessment of geriatric schizophrenic patients with severe impairment. Arch Clin Neuropsychol 2002; 17(7):611-623.
22. Goldberg TE, Kleinman JE, Daniel DG, et al. Dementia praecox revisited: age disorientation, mental status, and ventricular enlargement. Br J Psychiatry 1988; 153:187-190.
23. Liddle PF, Crow TJ. Age disorientation in chronic schizophrenia is associated with global intellectual impairment. Br J Psychiatry 1984; 144:193-199.
24. Harvey PD, Silverman JM, Mohs RC, et al. Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biol Psychiatry 1999; 45(1):32-40.
25. Friedman JI, Harvey PD, Coleman T, et al. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am J Psychiatry 2001; 158(9):1441-1448.
26. Harvey PD, Lombardi J, Kincaid MM, et al. Cognitive functioning in chronically hospitalized schizophrenic patients: age-related changes and age disorientation as a predictor of impairment. Schizophr Res 1995; 17:15-24.
27. Burich N, Crow TJ, Johnstone EC, et al. Age disorientation in chronic schizophrenia is not associated with pre-morbid intellectual impairment or past physical treatment. Br J Psychiatry 1988; 152:466-469.
28. Manschreck TC, Maher BA, Winzig L, et al. Age disorientation in schizophrenia: an indicator of progressive and severe psychopathology, not institutional isolation. J Neuropsychiatry Clin Neurosci 2000; 12(3):350-358.
29. Cox MD, Leventhal DB. A multivariate analysis and modification of a preattentive, perceptual dysfunction in schizophrenia. J Nerv Ment Dis 1978; 166(10):709-718.
30. Uhlhaas PJ, Phillips WA, Silverstein SM. The course and clinical correlates of dysfunctions in visual perceptual organization in schizophrenia during the remission of psychotic symptoms. Schizophr Res 2005; 75(2-3):183-192.
31. Buchanan RW, Strauss ME, Kirkpatrick B, et al. Neuropsychological impairments in deficit vs. nondeficit forms of schizophrenia. Arch Gen Psychiatry 1994; 51:804-812.
32. Silverstein SM, Matteson S, Knight RA. Reduced top-down influences in auditory perceptual organization in schizophrenia. J Abnorm Psychol 1996; 105(4):663-667.
33. Parnas J, Vianin P, Saebye D, et al. Visual binding abilities in the initial and advanced stages of schizophrenia. Acta Psychiatr Scand 2001; 103(3):171-180.
34. Doniger GM, Foxe JJ, Murray MM, et al. Impaired visual object recognition and dorsal/ventral stream interaction in schizophrenia. Arch Gen Psychiatry 2002; 59(11):1011-1020.
35. Rabinowicz EF, Silipo G, Goldman R, Javitt DC. Auditory sensory dysfunction in schizophrenia: imprecision or distractibility? Arch Gen Psychiatry 2000; 57(12):1149-1155.
36. Leitman DI, Foxe JJ, Butler PD, et al. Sensory contributions to impaired prosodic processing in schizophrenia. Biol Psychiatry 2005; 58(1):56-61.
37. Kraepelin E. Dementia praecox and paraphrenia. Edinburgh: E. & S. Livingstone; 1919.
38. Bleuler E. Dementia praecox or the group of schizophrenias. New York: International University Press; 1911.
39. Hegarty JD, Baldessarini RJ, Tohen M, et al. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 1994; 151(10):1409-1416.
40. Bowie CR, Harvey PD. Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr Clin North Am 2005; 28(3):613-633, 626.
41. Bilder RM, Goldman RS, Volavka J, et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 2002; 159(6):1018-1028.
42. Reichenberg A, Weiser M, Rapp MA, et al. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry 2005; 62(12):1297-1304.
43. Wilk CM, Gold JM, McMahon RP, et al. No, it is not possible to be schizophrenic yet neuropsychologically normal. Neuropsychology 2005; 19(6):778-786.
44. Davidson M, Reichenberg A, Rabinowitz J, et al. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry 1999; 156:1328-1335.
45. Thompson JL, Watson JR, Steinhauer SR, et al. Indicators of genetic liability to schizophrenia: a sibling study of neuropsychological performance. Schizophr Bull 2005; 31(1):85-96.
46. Mitropoulou V, Harvey PD, Zegarelli G, et al. Neuropsychological performance in schizotypal personality disorder: importance of working memory. Am J Psychiatry 2005; 162(10):1896-1903.
47. Addington J, Addington D. Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidol. Can J Psychiatry 1997; 42(9):983.
48. Bilder RM, Goldman RS, Robinson D, et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry 2000; 157(4):549-559.
49. Seidman LJ, Buka SL, Goldstein JM, Tsuang MT. Intellectual decline in schizophrenia: evidence from a prospective birth cohort 28 year follow-up study. J Clin Exp Neuropsychol 2006; 28(2):225-242.
50. Rund BR. A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophr Bull 1998; 24(3):425-435.
51. Granholm E, Morris S, Asarnow RF, et al. Accelerated age-related decline in processing resources in schizophrenia: evidence from pupillary responses recorded during the span of apprehension task. J Int Neuropsychol Soc 2000; 6(1):30-43.
52. Fucetola R, Seidman LJ, Kremen WS, et al. Age and neuropsychologic function in schizophrenia: a decline in executive abilities beyond that observed in healthy volunteers. Biol Psychiatry 2000; 48(2):137-146.
53. Blanchard JJ, Cohen AS. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull 2006; 32(2):238-245.
54. Keefe RS, Harvey PD, Lenzenweger MF, et al. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Res 1992; 44(2):153-165.
55. Carpenter WT Jr, Heinrichs DW, Wagman AM. Deficit and non-deficit forms of schizophrenia: the concept. Am J Psychiatry 1988; 145(5):578-583.
56. Rieckmann N, Reichenberg A, Bowie CR, et al. Depressed mood and its functional correlates in institutionalized schizophrenia patients. Schizophr Res 2005; 77(2-3):179-187.
57. Norholm V, Bech P. Quality of life in schizophrenic patients: association with depressive symptoms. Nord J Psychiatry 2006; 60(1):32-37.
58. Harvey PD. Reality monitoring in mania and schizophrenia. The association of thought disorder and performance. J Nerv Ment Dis 1985; 173(2):67-73.
59. Cohen JD, Servan-Schreiber D. Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia. Psychol Rev 1992; 99:45-77.
60. Barch DM, Berenbaum H. The effect of language production manipulations on negative thought disorder and discourse coherence disturbances in schizophrenia. Psychiatry Res 1997; 71:115-127.
61. Manschreck TC, Maher BA, Milavetz JJ, et al. Semantic priming in thought disordered schizophrenic patients. Schizophr Res 1988; 1(1):61-68.
62. Aloia MA, Gourovitch ML, Weinberger DR, Goldberg TE. An investigation of semantic space in patients with schizophrenia. J Int Neuropsychological Soc 1996; 2:267-273.